India's Drug Delivery Systems: From Solubility to Smart Implants

The Problems Being Solved

Many promising drugs never reach their full potential because they simply don't dissolve well enough in the body. In India, innovators are zeroing in on this solubility bottleneck for a wide range of hydrophobic compounds—think telmisartan, curcumin, berberine, and etoricoxib—where poor oral absorption limits efficacy.

Beyond solubility, chronic diseases demand more than a quick-release pill. The need for controlled, sustained release is driving work on systems that stay in the stomach longer, release drugs over days or weeks, or target specific tissues to minimize side effects. Patient convenience is equally critical: swallowing difficulties, the need for rapid onset, and frequent dosing all push for alternatives like oral films, sublingual strips, and transdermal patches.

Underpinning these efforts is a surge in novel carrier systems—polymeric micelles, solid lipid nanoparticles, dendrimers, and nanosponges—that encapsulate, protect, and deliver drugs more intelligently. And at the device end, automated dispensers, microneedle patches, and implantable systems are being designed for precise, long-acting administration, including for conditions like HIV.

• Enhancing dissolution of hydrophobic drugs: telmisartan, nifedipine, silybin, capecitabine, and others
• Gastro-retentive and mucoadhesive systems for once-daily dosing of drugs like obeticholic acid and piroxicam
• Topical and mucosal targeting to reduce systemic exposure—fluconazole, atorvastatin, curcumin
• Oral films, fast-dissolving softgels, and transdermal patches for better patient compliance
• Nanocarriers and lipid-based vesicles for improved encapsulation and stability
• Automated fluid dispensing, injection control, and implantable devices for precision delivery

How the Field Is Solving It

The technical response is as diverse as the problems. Polymeric micelles and nanoparticles use amphiphilic polymers to trap hydrophobic drugs in a water-friendly shell, dramatically boosting solubility and bioavailability. Solid dispersions and cyclodextrin complexes take a different route—dispersing the drug in a hydrophilic carrier or forming host-guest complexes to speed up dissolution.

Lipid-based systems are another workhorse. Solid lipid nanoparticles, liposomes, and ethosomes not only improve encapsulation but also enable controlled release and deeper skin penetration for topical therapies. For drugs that need to linger in the stomach or adhere to mucosal surfaces, floating and mucoadhesive formulations extend residence time and enhance absorption.

On the device side, microneedle patches with core-shell structures painlessly pierce the skin for transdermal delivery, while implantable systems promise months-long release for chronic conditions. Automated delivery devices—featuring robotic arms, reservoir supports, and aseptic transfer—are raising the bar for safety and precision in clinical and home settings.

• Polymeric micelles and nanoparticles for hydrophobic payloads
• Solid dispersions and cyclodextrin complexes to accelerate dissolution
• Lipid-based carriers (SLNs, liposomes, ethosomes) for encapsulation and topical delivery
• Mucoadhesive and gastro-retentive designs for prolonged GI residence
• Microneedle patches and implantable depots for transdermal and long-acting release
• Robotic and automated systems for precise fluid administration

Where the Market Is Heading

Globally, the drug delivery systems market is substantial and steadily growing. Fortune Business Insights estimates the market at roughly USD 48 billion in 2025, with a mid-single-digit annual growth rate through 2034. The broader advanced drug delivery space is even larger, while the electronic delivery segment alone was valued in the low tens of billions in 2024, according to Grand View Research.

Several trends are reshaping the field. Self-administration and wearable devices—insulin pumps, auto-injectors—are gaining ground for chronic disease management. AI and machine learning are being woven into formulation design to personalize release profiles, as noted by MedTech Outlook. Meanwhile, nanocarrier platforms originally developed for small molecules are now being adapted for mRNA and siRNA delivery, a shift highlighted by Mordor Intelligence. Smart, stimuli-responsive implants that release drugs based on physiological cues are moving from concept to early reality.

In India, the picture is one of focused momentum amid a cautious funding environment. Pharma startups are actively pursuing novel formulations and delivery tech, but overall investment has tightened to the low tens of millions, as reported by Express Pharma. On the regulatory front, proposed reforms could halve clinical trial approval timelines, a move that RAPS suggests may significantly accelerate development of new delivery systems in the country.

The White Space

While small-molecule delivery is advancing rapidly, the delivery of biologics, peptides, and nucleic acids remains a wide-open frontier. Most current Indian innovation clusters around conventional hydrophobic drugs; macromolecule delivery—requiring protection from degradation, targeted intracellular delivery, and sophisticated release kinetics—is only beginning to attract attention.

Smart, stimuli-responsive systems that automate dosing based on real-time physiological feedback are still nascent, presenting an opportunity to combine India's strengths in low-cost engineering with advanced materials. The growing push toward self-administration opens doors for user-friendly, affordable devices tailored to Indian healthcare settings. And with regulatory pathways potentially becoming faster, the window is widening for clinical validation of novel carriers and implantables. The next wave of innovation will likely come from bridging these gaps—making biologics delivery as routine as oral tablets, and embedding intelligence into the delivery system itself.

Explore the Innovators

The specific inventors, patents, and companies driving these advances in India—from nanosponge-based formulations to automated dispensing robots—can be explored in depth on Deeptech Navigator. The platform maps the people and ideas behind the patents, offering a direct view into where the country's drug delivery innovation is heading.

In our data

Sources

• Advances in drug delivery systems, challenges and future ... ↗
• Drug Delivery Systems: An Overview ↗
• Drug Delivery for Medical Treatment ↗
• A comprehensive guide to the pharmaceutical supply chain ↗
• Supply Chain Challenges in Pharmaceutical Manufacturing ... ↗
• Pharma Supply Chain: A Comprehensive Guide ↗
• Electronic Drug Delivery Systems Market Size Report, 2030 ↗
• Advanced Drug Delivery Systems Market Size, Report Analysis 2031 ↗